GE Healthcare Technologies Inc. (NASDAQ: GEHC) has recently announced the pricing of an upsized secondary underwritten public offering of 15,000,000 shares of its common stock at a public offering price of $86.00 per share. This marks an increase from the previously announced offering size of 10,000,000 GEHC shares. The offering is expected to close on September 16, 2024, subject to customary closing conditions.
The offering was made pursuant to an automatically effective shelf registration statement on Form S-3 with the U.S. Securities and Exchange Commission. The lead joint book-running managers for the offering are Morgan Stanley and Citigroup.
GE Healthcare is a global medical technology, pharmaceutical diagnostics, and digital solutions innovator, with a focus on providing integrated solutions, services, and data analytics to enhance efficiency in hospitals, improve the effectiveness of clinicians, and advance personalized patient care. The company has a workforce of approximately 51,000 colleagues and operates as a $19.6 billion business. The market has reacted to these announcements by moving the company's shares -0.6% to a price of $86.91. Check out the company's full 8-K submission here.
